Series A · BiotechPranaX Corporation: Series ADevelops exosome-based technologies for regenerative biologics and wellnessPublished Oct 4, 2026By RoundOS Funding deskFunding historyJan 29, 2026Series A · This round$17MSourcesprnewswire.com↗
Isomorphic LabsBuilds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas$5BSeries C · Nov 17, 2026
Marrow TherapeuticsMarrow Therapeutics develops bone marrow-targeted genetic medicines for severe blood disorders.$120MSeries B · Nov 17, 2026
Marrow TherapeuticsMarrow Therapeutics develops bone marrow-targeted genetic medicines for severe blood disorders.$53MSeries A financing disclosure · Nov 17, 2026
Science CorporationDevelops brain-computer interface retinal implants to restore vision in patients with retinal diseases$400MSeries D · Nov 17, 2026